SCHEMBL291894

SCHEMBL291894

CC1(C)CN(c2ccccc2)C(=O)CN1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
GAA P10253 2/20 0.43
KDM4E B2RXH2 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
DDB1 Q16531 1/20 0.43
CRBN Q96SW2 1/20 0.43
RAB9A P51151 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
NPC1 O15118 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
HSD11B1 P28845 1/20 0.40
SIGMAR1 Q99720 3/20 0.39
TMEM97 Q5BJF2 2/20 0.39
ADRB1 P08588 1/20 0.39
ADRA2C P18825 1/20 0.39
SLC6A2 P23975 1/20 0.39
HRH2 P25021 1/20 0.39
ADRA1D P25100 1/20 0.39
HTR7 P34969 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL292131 0.85 AR (0.43) GAARAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL291532 0.84 KMT2A (0.50) MAPTGAAKDM4EMEN1KMT2A
SCHEMBL291850 0.83 OPRM1 (0.49) MAPTGAAMEN1KMT2AHSD11B1
SCHEMBL292596 0.82 MAPT (0.50) MAPTTDP1ADRB1CYP1A2POLB
SCHEMBL27913504 0.81 AR (0.51) MAPTGAAKDM4ETDP1DDB1
SCHEMBL6818839 0.81 CTSG (0.42) MAPTGAAKDM4ECRBNRAB9A
SCHEMBL294226 0.80 DDB1 (0.49) MAPTKDM4ETDP1DDB1CRBN
SCHEMBL292679 0.79 HSD11B1 (0.46) MAPTKDM4ESMN1; SMN2HSD11B1SIGMAR1
SCHEMBL292960 0.79 MEN1 (0.53) MEN1KMT2ASMN1; SMN2SIGMAR1ALDH1A1
SCHEMBL291891 0.79 LMNA (0.47) MAPTGAAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158790-B2 Cyclic amine compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-04-17 US disclosed
EP-2036896-B1 CYCLIC AMINE COMPOUND DAIICHI SANKYO CO LTD (JP) 2012-03-14 EP disclosed
US-20090286807-A1 CYCLIC AMINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-19 US disclosed
EP-2036896-A1 CYCLIC AMINE COMPOUND Daiichi Sankyo Company, Limited (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286807-A1 CYCLIC AMINE COMPOUND HRH3, HRH4, H1-0 MAPT 4585/4885GAA 4317/4885KDM4E 920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.